“…Recent data shows that there exists a spectrum of genetic influences on AD development like common genetic variants with high risk for AD (SLC24A4, ZCWPW1, CELF1, FERMT2, HLA-DRB5/1, CASS4, INPP5D, MEF2C, NME8), rare genetic variants with low to high risk (AKAP9, AB13, PLCG2, SRCAP, TREM2) and other high-risk genes with moderate frequently expression (APOE4, SORL1) (Narayanan et al 2014;Campion, Charbonnier, and Nicolas 2019;Farrer et al 1997). Current investigations show the involvement of many modifiable risk factors for AD including inflammation, viral infections, Type 2 diabetes, vascular disorders, and hypertension (Edwards et al 2019;Stozická, Zilka, and Novák 2007). Among these risk factors, inflammation is considered as a central mechanism in AD and infectious agents like bacteria and viruses might play a critical role in sustaining chronic inflammation and inducing neuroinflammation.…”